Skip to main content

Table 2 Descriptive statistics from 91 cases of BHD

From: Bullous hemorrhagic dermatosis is an under-recognized side effect of full dose low-molecular weight heparin: a case report and review of the literature

Descriptor Statistic
Age in years, average ± SD 72 ± 12
Sex  % (n)
 Male 64% (58)
 Female 36% (33)
Anticoagulation drug,  % (n)
 Enoxaparin only 66% (61)
 Fondaparinux 12% (11)
 UFH only 9% (8)
 Bridging heparin + enoxaparin 6.5% (6)
 Other LMWH or ULMWH 5.4% (5)
 Coumadin only 1% (1)
Time to lesion onset, days, mean ± SD 7.0 ± 6.4
Location  % (n)
 Extremities only 67.9% (36)
 Extremities +torso 26.4% (14)
 Face, neck, head included 5.7% (3)
Management  % (n)
 Discontinued 57% (52)
 Continued 23.1% (21)
 Treatment changed or dose reduced 14.3% (13)
 Unknown 5.5% (5)
Time to resolution, days, mean ± SD 13.0 ± 7.4
 If continued any AC 13.9 ± 7.8
 Discontinued AC 12.1 ± 7.9